Lincoln Pharmaceuticals Ltd.
| BSE: 531633 | Sector: Health care |
| NSE: LINCOLN | ISIN Code: INE405C01035 |
| BSE 11:25 | 23 Jun | 312.45 |
-5.60 (-1.76%) |
OPEN
319.15 |
HIGH
320.05 |
LOW
311.00 |
| NSE 11:19 | 23 Jun | 312.45 |
-5.95 (-1.87%) |
OPEN
318.60 |
HIGH
320.50 |
LOW
310.35 |
| OPEN | 319.15 |
| PREVIOUS CLOSE | 318.05 |
| VOLUME | 2075 |
| 52-Week high | 338.85 |
| 52-Week low | 157.00 |
| P/E | 10.35 |
| Mkt Cap.(Rs cr) | 625 |
| Buy Price | 312.45 |
| Buy Qty | 15.00 |
| Sell Price | 313.05 |
| Sell Qty | 2.00 |
Lincoln Pharmaceuticals Ltd. (LINCOLN) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 947.65 | -4.85 | -0.51 | 13266.48 |
| Cipla | 960.60 | 4.95 | 0.52 | 12659.15 |
| Sun Pharma.Inds. | 669.95 | 3.50 | 0.53 | 12531.93 |
| Dr Reddy's Labs | 5333.50 | 26.30 | 0.50 | 11850.40 |
| Lupin | 1164.95 | 4.05 | 0.35 | 11025.66 |
| Apollo Hospitals | 3243.00 | -15.00 | -0.46 | 9794.50 |
| Glenmark Pharma. | 643.85 | 3.15 | 0.49 | 6712.63 |
| Alkem Lab | 3131.60 | -16.35 | -0.52 | 6677.08 |
| Cadila Health. | 628.40 | -1.50 | -0.24 | 6347.40 |
| Torrent Pharma. | 2922.25 | -4.65 | -0.16 | 6168.44 |
| Divi's Lab. | 4272.35 | -15.40 | -0.36 | 5310.57 |
| Alembic Pharma | 989.45 | -8.35 | -0.84 | 5051.44 |
| Ipca Labs. | 1996.50 | -8.05 | -0.40 | 4337.82 |
| Piramal Enterp. | 2485.75 | 39.55 | 1.62 | 4219.19 |
| Abbott India | 16492.05 | -181.00 | -1.09 | 4093.14 |
| Glaxosmi. Pharma | 1520.00 | 8.40 | 0.56 | 3224.68 |
| Jubilant Pharmo | 744.45 | -0.10 | -0.01 | 3139.90 |
| Sanofi India | 7669.15 | -24.95 | -0.32 | 2901.90 |
| Laurus Labs | 615.65 | 2.35 | 0.38 | 2797.34 |
| Ajanta Pharma | 1946.05 | -12.55 | -0.64 | 2718.59 |
Quick Links for Lincoln Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
